Agoracom Blog Home

Posts Tagged ‘investments’

Empower Clinics $CBDT.ca $EPWCF Subsidiary KAI Medical Laboratory Awarded #COVID-19 Testing & Healthcare Management Program for Five Million Square Foot Dallas Market Center, The Most Complete Wholesale Trade Resource in The World With $8 Billion USD In Annual Transactions $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 8:05 AM on Monday, February 1st, 2021

  • Awarded a long-term COVID-19 testing and healthcare management program for the Dallas Market Center, the leading wholesale marketplace in North America and the most complete wholesale trade resource in the world.
  • DMC is a five million square foot, global business-to-business trade center and the leading wholesale marketplace in North America connecting retailers and interior designers with top manufacturers in home décor, furniture, gifts, lighting and fashion.

VANCOUVER BC / February 1, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (EPWCF:OTCQB) (8EC:Frankfurt) (“Empower” or the “Company“) an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens each month, developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce that KAI Medical Laboratory has been awarded a long-term COVID-19 testing and healthcare management program for the Dallas Market Center (“DMC”), the leading wholesale marketplace in North America and the most complete wholesale trade resource in the world.

KAI TO PROVIDE DAILY ONSITE COVID TESTING TO KEEP FIVE MILLION SQUARE FOOT TRADE CENTER OPEN TO BUYERS AND SELLERS FROM AROUND THE WORLD

DMC is a five million square foot, global business-to-business trade center and the leading wholesale marketplace in North America connecting retailers and interior designers with top manufacturers in home décor, furniture, gifts, lighting and fashion. DMC markets events throughout the year attracting buyers and sellers from all 50 states and more than 80 countries, resulting in significant economic impact:

  • $8 Billion in annual wholesale transactions
  • $1.1 Billion in indirect local economic impact
  • $380 million in direct local economic impact

“We cannot recover from crises like the COVID-19 pandemic without a resilient retail sector and the market centers have a critical role in participating in that recovery,” said Harlan Crow, chairman of the company that owns DMC in a January 3, 2021 Forbes Article.

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/754316-empower-clinics-subsidiary-kai-medical-laboratory-awarded-covid-19-testing-healthcare-management-program-for-five-million-square-foot/messages/2301340#message

Datametrex $DM.ca $DTMXF Announces Another COVID-19 Test Kit Sales to Canadian Mining Company $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:59 AM on Monday, February 1st, 2021
  • Received a Purchase Order from a Canadian mining company for COVID-19 test kits manufactured by 1drop Inc., and ancillary products.
  • The total gross sales amount of the sales is approximately $250,000 CAD, excluding shipping and courier fees.
  • This brings approximately $2.8M sales to date to the Canadian mining companies.

Toronto, Ontario–(February 1, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”), is pleased to announce that it has received a Purchase Order (the “PO”) from a Canadian mining company (the “Purchaser”) for COVID-19 test kits manufactured by 1drop Inc. (“1drop”), and ancillary products. The total gross sales amount of the sales is approximately $250,000 CAD, excluding shipping and courier fees. This brings approximately $2.8M sales to date to the Canadian mining companies.

Under the terms of the sale to the Purchaser, Datametrex will provide 1drop COVID-19 qPCR Detection Kits, a PCR machine, an RNA extraction machine, and RNA extraction kits. Datametrex anticipates that it has a little or no upfront costs associated with the sale of the test kits. All of the items are shipped directly from manufacturers to the purchaser’s mine operating sites.

“This further confirms Datametrex’s approach with its diverse COVID-19 product portfolio of health security products and services,” stated Marshall Gunter, CEO of Datametrex.

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/754315-datametrex-announces-another-covid-19-test-kit-sales-to-canadian-mining-company/messages/2301339#message

Draganfly $DFLY.ca $DFLYF to Host Shareholder Update Call $FLT.ca $UAVS $ALPP

Posted by AGORACOM-JC at 9:41 AM on Monday, January 25th, 2021

Update to Include Discussion with Vaccine Drone Delivery, Vital Intelligence Screening and Varigard Spraying Customers

  • Announced today that it will host a virtual-only shareholder update call on January 28, 2021 at 2PM MST/4PM EST.
  • The shareholder update call will be facilitated by Draganfly CEO, Cameron Chell, who will provide a corporate update, Draganfly’s current projects, customers, recent sales as well as facilitating a pre-submitted and live chat questions and answers.

Los Angeles, CA, Jan. 25, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solution developer and operator, announced today that it will host a virtual-only shareholder update call on January 28, 2021 at 2PM MST/4PM EST.

The shareholder update call will be facilitated by Draganfly CEO, Cameron Chell, who will provide a corporate update, Draganfly’s current projects, customers, recent sales as well as facilitating a pre-submitted and live chat questions and answers.

Special guests on the call will include the following Draganfly customers:

Wayne Williams, CEO of Coldchain Technology Services, LLC. Draganfly recently announced that it has been selected by Coldchain Technology Services to design, build and operate a turnkey vaccine and medical delivery service for remote and challenged locations. Joining this conversation will be Justin Hannewyk, President of Draganfly’s subsidiary that oversees flight services.

William Santana Li, CEO of Knightscope, Inc. Draganfly recently announced that it has been selected by Knightscope to integrate mobile vital sign screening technology into its autonomous security robots and security applications. The technology implemented by Draganfly can measure key vital signs. The system uses an advanced microcontroller to perform sophisticated image processing in real time, while consuming less than 50W of electrical power. Despite its small size and power consumption, this fully featured system has a web-based API that works seamlessly with Knightscope’s autonomous security platform.

Dr. Quinton Ross, President of Alabama State University. Draganfly recently announced that it has been selected by Alabama State University to provide drone spraying services for its stadium and basketball arena of Draganfly’s proprietary Varigard disinfectant, which provides a up to 24hr + protective COVID pathogen kill zone and spread retardant layer to surfaces.

“2021 has just started and Draganfly has already announced important corporate initiatives, as well as made several customer and engineering announcements,” said Cameron Chell, CEO of Draganfly. “We are looking forward to providing a full update on our progress.”

Read More: https://agoracom.com/ir/Draganfly/forums/discussion/topics/753853-draganfly-to-host-shareholder-update-call/messages/2300034#message

Draganfly $DFLY.ca $DFLYF CEO Cameron Chell to be Featured on Yahoo Finance $FLT.ca $UAVS $ALPP

Posted by AGORACOM-JC at 9:36 AM on Friday, January 22nd, 2021
  • Announced today that the CEO of the Company, Cameron Chell, will be featured on Yahoo Finance.
  • Segment on Yahoo Finance will focus on Draganfly’s recent announcements in relation to Draganfly’s robust vaccine delivery payload for drone delivery of the COVID-19 vaccine.

Los Angeles, CA, Jan. 22, 2021 — Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“ Draganfly ” or the “ Company ”), an award-winning, industry-leading manufacturer and systems developer‎, announced today that the CEO of the Company, Cameron Chell, will be featured on Yahoo Finance.

The segment on Yahoo Finance will focus on Draganfly’s recent announcements in relation to Draganfly’s robust vaccine delivery payload for drone delivery of the COVID-19 vaccine.

“We are honored to join Yahoo Finance and discuss Draganfly’s vaccine drone delivery payload system,” said Cameron Chell, CEO Draganfly. “We are eager to develop this payload and service as we can leverage our extensive patent portfolio as well as secure auto-pilot and flight management system to help with the distribution of the vaccine for COVID-19 and beyond.”

Cameron Chell’s segment on Yahoo Finance will air at 1040AM ET on Friday, January 22.

Read More: https://agoracom.com/ir/Draganfly/forums/discussion/topics/753667-draganfly-ceo-cameron-chell-to-be-featured-on-yahoo-finance/messages/2299467#message

Datametrex $DM.ca $DTMXF Announces Definitive Agreement with Concierge Medical $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:51 AM on Friday, January 22nd, 2021
  • Announced that further to its press release dated January 7, 2021, it has entered into a share exchange agreement with Concierge Medical Consultants Inc. and the shareholders of Concierge effective January 19, 2021 to acquire 100% of Concierge’s issued and outstanding securities
  • Concierge is an arm’s length private telehealth and medical concierge services company incorporated under the laws of British Columbia.

Toronto, Ontario–(January 22, 2021) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex) is pleased to announce that further to its press release dated January 7, 2021, it has entered into a share exchange agreement with Concierge Medical Consultants Inc. (“Concierge“) and the shareholders of Concierge (the “Concierge Shareholders“) effective January 19, 2021 (the “Definitive Agreement“) to acquire 100% of Concierge’s issued and outstanding securities (the “Transaction“). Concierge is an arm’s length private telehealth and medical concierge services company incorporated under the laws of British Columbia.

“Health care is on the verge of a revolution, one that will be driven by A.I. technologies. Medical services are already strained by the growing demand for healthcare worldwide. By leveraging A.I. technologies, medical we will be able to provide services more quickly and accurately,” said Marshall Gunter, CEO of Datametrex.

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/753658-datametrex-announces-definitive-agreement-with-concierge-medical/messages/2299447#message

VIDEO – Empower Clinics $CBDT.ca $EPWCF CEO Answers Shareholder Questions In First Ever Shareholder Q&A $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 9:20 PM on Thursday, January 21st, 2021

On behalf of Steve and the Empower Clinics team, we are happy to present the first ever Empower Clinics Shareholder Q&A.  

Thanks to all investors that posted their questions here on AGORACOM and on Twitter.

Enjoy this video with Steve from an undisclosed location that he reveals during the interview.

Draganfly $DFLY.ca $DFLYF Selected to Provide Engineering and Development Services for Drone Based Air Support Defense System $FLT.ca $UAVS $ALPP

Posted by AGORACOM-JC at 9:26 AM on Thursday, January 21st, 2021
  • Selected to provide engineering and development services for a drone-based Air Support Defense System for Integrated Launcher Solutions Inc.
  • Integrated Launcher Solutions Inc. is a systems development and technical integration services company headquartered in Ontario with operations in Florida, with a vision to continually improve launch, range and space systems for its client base of US defense organizations and contractors.
  • Draganfly will provide Integrated Launcher Solutions Inc. development and engineering expertise and services for the deployment of a non-lethal 40mm multi-launching system that can be mounted and deployed on drones, robots and other remote or autonomous platforms.

Los Angeles, CA, Jan. 21, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, today announced it has been selected to provide engineering and development services for a drone-based Air Support Defense System for Integrated Launcher Solutions Inc. (“ILS”)

Integrated Launcher Solutions Inc. is a systems development and technical integration services company headquartered in Ontario with operations in Florida, with a vision to continually improve launch, range and space systems for its client base of US defense organizations and contractors.

Draganfly will provide Integrated Launcher Solutions Inc. development and engineering expertise and services for the deployment of a non-lethal 40mm multi-launching system that can be mounted and deployed on drones, robots and other remote or autonomous platforms. The main use case of the launch system is public disturbance management for military and public safety organizations.

“ILS approached Draganfly for this project because we are extremely impressed with their innovation in engineering,” said Greg Sullivan, CEO, Integrated Launcher Solutions. “Our client base requires North American developed and made solutions. Draganfly has the expertise to get this project executed.”

“We are honored at the confidence that Integrated Launcher Solutions has placed with Draganfly in overseeing the development of this very important drone technology,” said Cameron Chell, CEO Draganfly. “I am confident that the Draganfly team will provide the right set of expertise and management to develop the non-lethal ILS Air support Defense System.”

Read More: https://agoracom.com/ir/Draganfly/forums/discussion/topics/753565-draganfly-selected-to-provide-engineering-and-development-services-for-drone-based-air-support-defense-system/messages/2299226#message

Empower Clinics $CBDT.ca $EPWCF Doubling KAI Medical Laboratory Size In Anticipation Of Test Volumes By End Of Q1. Files MDEL Application With Health Canada To Import and Sell KAI Saliva PCR Test In Canada $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 7:58 AM on Thursday, January 21st, 2021

  • Announced significant expansion of our KAI Medical Laboratory in Dallas, Texas in anticipation of projected growth in COVID-19 testing requirements in the U.S., Canada and international markets.
  • In addition, Empower has filed a Medical Device Establishment Licence with Health Canada for the purposes of importing, distributing and selling our KAI Medical COVID-19 Saliva Test, which has experienced immediate success since it’s launch on December 15, 2020 in the United States and reported on January 7, 2021.

VANCOUVER, BC / January 21, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company“) an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce significant expansion of our KAI Medical Laboratory in Dallas, Texas in anticipation of projected growth in COVID-19 testing requirements in the U.S., Canada and international markets.

In addition, Empower has filed a Medical Device Establishment Licence (“MDEL”) with Health Canada for the purposes of importing, distributing and selling our KAI Medical COVID-19 Saliva Test (“KAI Saliva”), which has experienced immediate success since it’s launch on December 15, 2020 in the United States and reported on January 7, 2021.

KAI MEDICAL LABORATORY EXPANDING TO AT LEAST DOUBLE CURRENT SIZE IN ANTICIPATION OF ANTICIPATED GROWTH IN VOLUME

KAI Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and the travel industry. KAI experienced significant growth in its first quarter under Empower, with Q4 COVID-19 test kit volumes exceeding 6,000 units, far surpassing the 1,300 total units prior to acquisition.

Current run rate projections now indicate as follows:

  • January 2021 is expected to exceed 8,000 tests, surpassing all of Q4 2020
  • February 2021 could see daily rates hit 1,000 tests per day
  • March 2021 could see daily rates hit 2,000 tests per day

These run rates DO NOT include the recent 25,000 unit order for KAI Saliva test kits, nor do they include any test kits from the launch of KAItests.com

Empower Clinics CEO, Steven McAuley stated “Our investment in R&D is really starting to pay off for KAI Medical, starting with a new state-of-art laboratory information system to automate processes for the anticipated growth in volume. Next, we have hired three new scientists, increased administrative staff and are activating a call center to provide world-class customer support. Further, the investment in new test protocols such as the Kai Saliva test kit, combined with our Health Canada medical device licence, positions us to be a leader in the reactivation of travel for Canadians.”

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/753555-empower-clinics-doubling-kai-medical-laboratory-size-in-anticipation-of-test-volumes-by-end-of-q1-files-mdel-application-with-health-canada-to/messages/2299214#message

Datametrex $DM.ca $DTMXF Expands LOTTE Agreements $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:59 AM on Wednesday, January 20th, 2021
  • Announced that it has renewed and extended its current sales agreements on January 15, 2021, with LOTTE Global Logis, LOTTE Duty-Free Shops, and LOTTE Home Shopping, LOTTE Super, collectively LOTTE for technology services and maintenance.
  • The aggregate gross revenue from these agreements is approximately $500,000 CAD with the gross margin of $259,000.

Toronto, Ontario–(January 20, 2021) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”), is pleased to announce that it has renewed and extended its current sales agreements on January 15, 2021, with LOTTE Global Logis, LOTTE Duty-Free Shops, and LOTTE Home Shopping, LOTTE Super, collectively LOTTE (“LOTTE”) for technology services and maintenance. The aggregate gross revenue from these agreements is approximately $500,000 CAD with the gross margin of $259,000.

Datametrex is a continued preferred vendor partner for LOTTE, and vendors on this platform have demonstrated quality, reliability, and trustworthiness.

“These extended agreements with LOTTE further confirm Datametrex’s business strategy for generating revenue from its diverse portfolio of AI technology and cybersecurity products,” commented Marshall Gunter, CEO of Datametrex.

Source: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/753446-datametrex-expands-lotte-agreements/messages/2299012#message

Empower Clinics $CBDT.ca $EPWCF Announces First Ever AGORACOM Video Q&A with Shareholders Submitting Questions for Direct Response by CEO Steven McAuley $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 7:47 AM on Tuesday, January 19th, 2021

Shareholders are able to submit questions by either:

  • Posting directly to the Empower Verified Forum on AGORACOM at https://agoracom.com/ir/EmpowerClinics/forums/discussion and checking the “?” box
  • Posting on Twitter to both @EmpowerClinics and @Agoracom with the any of the following hashtags #empowerclinics_QA, #CBDTQA, #CBDT_QA

Questions must be posted by no later than Wednesday, January 20th, 5PM EST.

With Empower Clinics Entering Growth Phase On Multiple Business Fronts, Chairman & CEO Steven McAuley Provides Shareholders With An Opportunity To Fully Participate In Company’s First AGORACOM Video Q&A

VANCOUVER, BC / January 19, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical clinics in USA and Canada, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce its first ever AGORACOM Video Q&A, which provides investors with the opportunity to submit questions for response by Chairman & CEO Steven McAuley.

Empower Clinics CEO Steven McAuley stated “With so much tremendous progress taking place for our company, as we head into what I expect to be our breakthrough and greatest year ever in 2021, I want to make sure shareholders have an opportunity to ask questions, receive answers directly from me and begin the process of regular engagement through our Verified Forum on AGORACOM. I am looking forward to engaging with shareholders and followers on the interview.”

VIDEO Q&A DETAILS

Shareholders are able to submit questions by either:

  • Posting directly to the Empower Verified Forum on AGORACOM at https://agoracom.com/ir/EmpowerClinics/forums/discussion and checking the “?” box
  • Posting on Twitter to both @EmpowerClinics and @Agoracom with the any of the following hashtags #empowerclinics_QA, #CBDTQA, #CBDT_QA

Questions must be posted by no later than Wednesday, January 20th, 5PM EST.

Read more: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/753351-empower-clinics-announces-first-ever-agoracom-video-q-a-with-shareholders-submitting-questions-for-direct-response-by-ceo-steven-mcauley/messages/2298759#message